Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia Edition

Research To Practice | Oncology Videos · Apr 12, 2023 · 1h 19m

Featuring an interview with Dr John Allan, including the following topics:

• Update on key studies of acalabrutinib in the front-line setting (0:00)

• Updated data from the GLOW study: First-line fixed-duration ibrutinib and venetoclax compared to chlorambucil and Obinutuzumab (21:11)

• Treatment outcomes after achieving undetectable minimal residual disease (MRD) with first-line ibrutinib and venetoclax: Updated analysis of the CAPTIVATE trial (35:06)

• Ibrutinib/venetoclax with MRD-driven duration of treatment: Updated analysis of the FLAIR trial (48:08)

• Acalabrutinib with venetoclax and…